Exact Sciences pockets $238M from secondary stock sale — 3 key notes

Exact Sciences sold an additional 7 million shares for a gross proceeds of $245 million, the Wisconsin State Journal reports.

Here's what you should know:

1. After fees, Exact Sciences will make approximately $238 million.

2. Several investment firms can sell up to 1.05 million more shares of Exact Sciences if buyers demand it.

3. As of April 29, Exact Sciences had 111.2 million shares of common stock.

More articles on gastroenterology:
CEO compensation for 10 GI companies for the last 3 years
Gastroenterologists ignoring H.pylori guidelines, survey says
5 stats on GI net revenue per case at multispecialty ASCs

© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months